NCT05248633View on ClinicalTrials.gov

Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary Plasmacytoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

April 21, 2022

Primary Completion Date

April 30, 2026

Study Completion Date

October 31, 2026

Conditions
Solitary Plasmacytoma
Interventions
RADIATION

radiotherapy

radiotherapy with a dose of 40-50 Gy

DRUG

Bortezomib Injection

subcutaneous Bortezomib 1.3mg/m2 d1,8,15,22

DRUG

Lenalidomide

Lenalidomide 25mg for 21 days

DRUG

Dexamethasone

Dexamethasone 40mg d1,8,15,22

Trial Locations (1)

Unknown

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER